The ER/AP1 Pathway: A Window on the Cell-Specific Estrogen-like Effects of Antiestrogens
We study an unusual pathway of estrogen receptor (ER) action, in which ER indirectly alters the transactivation capacity of the jun/fos complex (AP1 proteins), rather than stimulating gene expression by directly binding DNA. Here, we review the rationale for studying this pathway and the reasons for thinking that elucidation of ER/AP1 interactions will help us design the next generation of antiestrogens and hormone replacement therapies.
KeywordsEstrogen Serine Dexamethasone Tamoxifen Glucocorticoid
Unable to display preview. Download preview PDF.
- Anonymous (1992) Breast cancer prevention trial will recruit 16 000 women. Oncology (Williston Park) 6: 57–58Google Scholar
- Birkedal-Hansen H, Moore W, Bodden M, Windsor L, Birkedal-Hansen B, De-Carlo A, Engler J (1993) Matrix metalloproteases; a review. Oral Biol Med 4: 197–250Google Scholar
- Huynh HT, Pollak M (1993) Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res 23: 5585–5588Google Scholar
- Jamil A, Croxtall JD, White J O (1991) The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells ( Ishikawa ). J Mol Endocrinol 6: 215–21Google Scholar
- Parker MG (1990) Mechanisms of action of steroid receptors in the regulation of gene transcription. J Reprod Fertil 2: 717–720Google Scholar
- Tora L, Gaub MP, Mader S, Dierich A, Bellard M, Chambon P (1988) Cell-specific activity of a GGTCA half-palindromic oestrogen-responsive element in the chicken ovalbumin gene promoter. EMBO J 12: 3771–3778Google Scholar
- Zhou F, Bouillard B, Pharaboz-Joly MO, Andre J (1989) non-classical antiestrogenic actions of dexamethasone in variant MCF7 breast cancer cells in culture. Mol Cell Endocrinol 66: 189–197Google Scholar